PHARMACOLOGY EXAM #2 PRACTICE QUESTIONS
AND ANSWERS
A patient is taking two prescription medications that both
cause bradycardia. The nurse should monitor the patient for
which type of effect?
A. An increased therapeutic effect
B. An increased adverse effect
C. A reduced therapeutic effect
D. A reduced adverse effect - ANSWER->B. An increased
adverse effect
Which individual is at the highest risk for a drug-drug
interaction?
A. A toddler who is prescribed two antibiotics for a serious
infection
B. An adolescent who takes over-the-counter medications for
menstrual cramping
C. An adult who takes eight prescription medications for a
chronic condition
D. An older adult who takes two prescription medications and a
dietary supplement for anxiety - ANSWER->C. An adult who
takes eight prescription medications for a chronic condition
, The nurse cares for a patient who is taking a calcium channel
blocker for hypertension. The nurse should be most concerned
if the patient makes which statement?
A. "I take my medication with a glass of water."
B. "I eat foods high in fiber to prevent constipation."
C. "I drink a glass of grapefruit juice each evening."
D. "I avoid foods such as broccoli and cabbage." - ANSWER->C.
"I drink a glass of grapefruit juice each evening."
A patient is prescribed a medication to be taken on an empty
stomach. Which statement should the nurse include when
providing patient teaching?
A. "Take the medication 1 hour before eating."
B. "Take the medication with a small glass of water."
C. "Take the medication before going to bed at night."
D. "Take the medication 1 hour after a meal." - ANSWER->A.
"Take the medication 1 hour before eating."
Which patient does the nurse identify as being at highest risk
for the development of an adverse drug reaction?
A. A 1-month-old patient whose mother has allergies to
penicillin, aspirin, and codeine
B. A 16-year-old patient with multiple traumatic injuries who is
taking morphine and an antibiotic
C. A 54-year-old patient with multiple sclerosis who has been
enrolled in a clinical trial of a new drug
AND ANSWERS
A patient is taking two prescription medications that both
cause bradycardia. The nurse should monitor the patient for
which type of effect?
A. An increased therapeutic effect
B. An increased adverse effect
C. A reduced therapeutic effect
D. A reduced adverse effect - ANSWER->B. An increased
adverse effect
Which individual is at the highest risk for a drug-drug
interaction?
A. A toddler who is prescribed two antibiotics for a serious
infection
B. An adolescent who takes over-the-counter medications for
menstrual cramping
C. An adult who takes eight prescription medications for a
chronic condition
D. An older adult who takes two prescription medications and a
dietary supplement for anxiety - ANSWER->C. An adult who
takes eight prescription medications for a chronic condition
, The nurse cares for a patient who is taking a calcium channel
blocker for hypertension. The nurse should be most concerned
if the patient makes which statement?
A. "I take my medication with a glass of water."
B. "I eat foods high in fiber to prevent constipation."
C. "I drink a glass of grapefruit juice each evening."
D. "I avoid foods such as broccoli and cabbage." - ANSWER->C.
"I drink a glass of grapefruit juice each evening."
A patient is prescribed a medication to be taken on an empty
stomach. Which statement should the nurse include when
providing patient teaching?
A. "Take the medication 1 hour before eating."
B. "Take the medication with a small glass of water."
C. "Take the medication before going to bed at night."
D. "Take the medication 1 hour after a meal." - ANSWER->A.
"Take the medication 1 hour before eating."
Which patient does the nurse identify as being at highest risk
for the development of an adverse drug reaction?
A. A 1-month-old patient whose mother has allergies to
penicillin, aspirin, and codeine
B. A 16-year-old patient with multiple traumatic injuries who is
taking morphine and an antibiotic
C. A 54-year-old patient with multiple sclerosis who has been
enrolled in a clinical trial of a new drug
